Asimov
Asimov builds a mammalian synthetic biology platform—combining wet-lab tools, computer-aided design software, and machine learning—to program living cells for biologics and gene therapy development. It partners with biotech and pharmaceutical companies to design and optimize cell lines and manufacturing processes, offering software and R&D services around parts, circuits, and process development. Founded in 2017 and headquartered in Boston, it is privately held.
Open Positions at Asimov
1 open position
Own the end-to-end lab data platform that transforms biotech instrument and experiment data into traceable, ML-ready datasets and software services. This hybrid data and backend engineering role works closely with scientists to make lab data more standardized, usable, and actionable.